Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Beate Kampmann

Biographic Data

ID7750497
NAMEBeate Kampmann
GIVEN NAMESBeate
FAMILY NAMEKampmann
SIGNATUREKAMPMANN B
AFFILIATIONSLondon School of Hygiene & Tropical Medicine
ORCID0000-0002-6546-4709
VERIFIEDYes
TOTAL WORKS14
TOTAL CITATIONS0
WORKS AS AUTHOR14
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2014
LATEST PUBLICATION YEAR2025
H-INDEX0
  • Beyond proximity

    Open Access•Oghenebrume Wariri, Winfred Dotse‐Gborgbortsi et al.•ARTICLE•BMJ Global Health•2025

    INTRODUCTION: Stillbirths are disproportionately concentrated in sub-Saharan Africa, where geographical accessibility to basic/comprehensive emergency obstetric and newborn care (BEmONC and CEmONC) significantly influences maternal and perinatal outcomes. This study describes stillbirth rates within healthcare facilities in The Gambia and examines their distribution in relation to the geographical accessibility of these facilities. METHODS: We an…

  • “I live with pain, it cannot go away”

    Open Access•Esin Nkereuwem, Oluwatosin Nkereuwem et al.•ARTICLE•PLOS Global Public Health•2025

    Childhood and adolescent tuberculosis (TB) survivors often face ongoing challenges even after completing their treatment. While the biomedical aspects of TB recovery are well studied, there is still limited understanding of how young survivors cope with the long-term impact of TB on their daily lives, development, and aspirations. Guided by an illness-narrative and phenomenological perspective, this qualitative study explored the lived experience…

  • Serological survey to determine measles and rubella immunity gaps across age and geographic locations in The Gambia

    Open Access•Oghenebrume Wariri, Abdul Khalie Muhammad et al.•ARTICLE•Global Health Action•2025

    Vaccine coverage and disease surveillance data are valuable for monitoring protection against vaccine-preventable diseases; however, they do not directly measure population immunity. High-quality, representative serological studies can provide key insights into immunity gaps, outbreak susceptibility, and inform targeted vaccination strategies, even in high-performing immunization programs. This study aims to estimate location-specific and age-spe…

  • Operationalizing African self-reliance in vaccine manufacturing

    Open Access•Chiluba Mwila, Anna Mia Ekström et al.•ARTICLE•Global Health Action•2025

    The COVID-19 pandemic underscored Africa's urgent need for vaccine security and self-reliance. In response, the African Union and Africa Centers for Disease Control and Prevention (CDC) established the Framework for Action (FFA) through the Platform for Harmonized African Health Products Manufacturing (PHAHM), with a goal of 60% local vaccine production by 2040. During 2024, Africa CDC, Karolinska Institutet, and Charité Universitätsmedizin Berli…

  • Maternal and perinatal health research during emerging and ongoing epidemic threats

    Open Access•Mercedes Bonet, Magdalena Babinska et al.•ARTICLE•BMJ Global Health•2024

    INTRODUCTION: Pregnant women and their offspring are often at increased direct and indirect risks of adverse outcomes during epidemics and pandemics. A coordinated research response is paramount to ensure that this group is offered at least the same level of disease prevention, diagnosis, and care as the general population. We conducted a landscape analysis and held expert consultations to identify research efforts relevant to pregnant women affe…

  • Life Science 2.0

    Open Access•Michaela Vallin, G Tomson et al.•ARTICLE•Global Health Action•2024

    The COVID-19 pandemic put the life science sector to the test. Vaccines were developed at unprecedented speed, benefiting from decades of fundamental research and now honoured by a Nobel Prize. However, we saw that the fruits of science were inequitably distributed. Most low- and middle-income countries were left behind, deepening the inequalities that the Sustainable Development Goals were set to reduce. We argue that the life science sector mus…

  • Beyond buzzwords

    Open Access•Maeve Cook-Deegan, Kerem Böge et al.•ARTICLE•Global Health Action•2024

    BACKGROUND: Germany has increased its political and financial commitment for global health, but this needs to be backed by a robust global health research ecosystem with strong partnerships in low- and middle-income countries (LMICs). OBJECTIVE: This article suggests pathways for empowering researchers to operate beyond their disciplinary silos and strengthen partnerships across sectors and countries. The authors identify barriers and enablers of…

  • Covid-19 vaccination implementation in 52 African countries

    Open Access•Oghenebrume Wariri, Muhammed O Afolabi et al.•ARTICLE•BMJ Global Health•2023

    INTRODUCTION: To end the COVID-19 pandemic, the WHO set a goal in 2021 to fully vaccinate 70% of the global population by mid-2022. We projected the COVID-19 vaccination trajectory in 52 African countries and compared the projected to the 'actual' or 'observed' coverage as of December 2022. We also estimated the required vaccination speed needed to have attained the WHO 70% coverage target by December 2022. METHODS: We obtained publicly available…

  • Impact of the Covid-19 pandemic on the coverage and timeliness of routine childhood vaccinations in the Gambia, 2015–2021

    Open Access•Oghenebrume Wariri, C Edson Utazi et al.•ARTICLE•BMJ Global Health•2023

    INTRODUCTION: The COVID-19 pandemic caused widespread morbidity and mortality and resulted in the biggest setback in routine vaccinations in three decades. Data on the impact of the pandemic on immunisation in Africa are limited, in part, due to low-quality routine or administrative data. This study examined coverage and timeliness of routine childhood immunisation during the pandemic in The Gambia, a country with an immunisation system considere…

  • Timeliness of routine childhood vaccination in 103 low-and middle-income countries, 1978–2021

    Open Access•Oghenebrume Wariri, Uduak Okomo et al.•ARTICLE•PLOS Global Public Health•2022

    Empiric studies exploring the timeliness of routine vaccination in low-and middle-income countries (LMICs) have gained momentum in the last decade. Nevertheless, there is emerging evidence suggesting that these studies have key measurement and methodological gaps that limit their comparability and utility. Hence, there is a need to identify, and document these gaps which could inform the design, conduct, and reporting of future research on the ti…

  • Conducting clinical research in a resource-constrained setting

    Open Access•Abdulazeez Imam, Oghenebrume Wariri et al.•ARTICLE•BMJ Global Health•2021

    Clinical research conducted to Good Clinical Practice (GCP) standards is increasingly being undertaken in resource-constrained low-income and middle-income countries (LMICs) settings. This presents unique challenges that differ from those faced in high-income country (HIC) contexts, due to a dearth of infrastructure and unique socio-cultural contexts. Field experiences by research teams working in these LMIC contexts are thus critical to advancin…

  • Vaccine wastage in The Gambia

    Open Access•Effua Usuf, Grant Mackenzie et al.•ARTICLE•BMC Public Health•2018

    National projected wastage targets were met for the multi-dose/single dose vials, but for lyophilised vaccines, the target was only met in the largest major health facility

  • Why the Convention on the Rights of the Child must become a guiding framework for the realization of the rights of children affected by tuberculosis

    Open Access•Robindra Basu Roy, Nicola Brandt et al.•ARTICLE•BMC International Health and…•2016

    BACKGROUND: Until recently, paediatric tuberculosis (TB) has been relatively neglected by the broader TB and the maternal and child health communities. Human rights-based approaches to children affected by TB could be powerful; however, awareness and application of such strategies is not widespread. DISCUSSION: We summarize the current challenges faced by children affected by TB, including: consideration of their family context; the limitations o…

  • Achieving comprehensive childhood immunization

    Open Access•Sarah Payne, John Townend et al.•ARTICLE•Health Policy and Planning•2014•References: 17

    INTRODUCTION: Immunization is a vital component in the drive to decrease global childhood mortality, yet challenges remain in ensuring wide coverage of immunization and full immunization, particularly in low- and middle-income countries. This study assessed immunization coverage and the determinants of immunization in a semi-rural area in The Gambia. METHODS: Data were drawn from the Farafenni Health and Demographic Surveillance System. Children …

No prominent works on this page.

  • Achieving comprehensive childhood immunization

    Open Access•Sarah Payne, John Townend et al.•ARTICLE•Health Policy and Planning•2014•References: 17

    INTRODUCTION: Immunization is a vital component in the drive to decrease global childhood mortality, yet challenges remain in ensuring wide coverage of immunization and full immunization, particularly in low- and middle-income countries. This study assessed immunization coverage and the determinants of immunization in a semi-rural area in The Gambia. METHODS: Data were drawn from the Farafenni Health and Demographic Surveillance System. Children …

  • Why the Convention on the Rights of the Child must become a guiding framework for the realization of the rights of children affected by tuberculosis

    Open Access•Robindra Basu Roy, Nicola Brandt et al.•ARTICLE•BMC International Health and…•2016

    BACKGROUND: Until recently, paediatric tuberculosis (TB) has been relatively neglected by the broader TB and the maternal and child health communities. Human rights-based approaches to children affected by TB could be powerful; however, awareness and application of such strategies is not widespread. DISCUSSION: We summarize the current challenges faced by children affected by TB, including: consideration of their family context; the limitations o…

  • Vaccine wastage in The Gambia

    Open Access•Effua Usuf, Grant Mackenzie et al.•ARTICLE•BMC Public Health•2018

    National projected wastage targets were met for the multi-dose/single dose vials, but for lyophilised vaccines, the target was only met in the largest major health facility

  • Conducting clinical research in a resource-constrained setting

    Open Access•Abdulazeez Imam, Oghenebrume Wariri et al.•ARTICLE•BMJ Global Health•2021

    Clinical research conducted to Good Clinical Practice (GCP) standards is increasingly being undertaken in resource-constrained low-income and middle-income countries (LMICs) settings. This presents unique challenges that differ from those faced in high-income country (HIC) contexts, due to a dearth of infrastructure and unique socio-cultural contexts. Field experiences by research teams working in these LMIC contexts are thus critical to advancin…

  • Timeliness of routine childhood vaccination in 103 low-and middle-income countries, 1978–2021

    Open Access•Oghenebrume Wariri, Uduak Okomo et al.•ARTICLE•PLOS Global Public Health•2022

    Empiric studies exploring the timeliness of routine vaccination in low-and middle-income countries (LMICs) have gained momentum in the last decade. Nevertheless, there is emerging evidence suggesting that these studies have key measurement and methodological gaps that limit their comparability and utility. Hence, there is a need to identify, and document these gaps which could inform the design, conduct, and reporting of future research on the ti…

  • Covid-19 vaccination implementation in 52 African countries

    Open Access•Oghenebrume Wariri, Muhammed O Afolabi et al.•ARTICLE•BMJ Global Health•2023

    INTRODUCTION: To end the COVID-19 pandemic, the WHO set a goal in 2021 to fully vaccinate 70% of the global population by mid-2022. We projected the COVID-19 vaccination trajectory in 52 African countries and compared the projected to the 'actual' or 'observed' coverage as of December 2022. We also estimated the required vaccination speed needed to have attained the WHO 70% coverage target by December 2022. METHODS: We obtained publicly available…

  • Impact of the Covid-19 pandemic on the coverage and timeliness of routine childhood vaccinations in the Gambia, 2015–2021

    Open Access•Oghenebrume Wariri, C Edson Utazi et al.•ARTICLE•BMJ Global Health•2023

    INTRODUCTION: The COVID-19 pandemic caused widespread morbidity and mortality and resulted in the biggest setback in routine vaccinations in three decades. Data on the impact of the pandemic on immunisation in Africa are limited, in part, due to low-quality routine or administrative data. This study examined coverage and timeliness of routine childhood immunisation during the pandemic in The Gambia, a country with an immunisation system considere…

  • Maternal and perinatal health research during emerging and ongoing epidemic threats

    Open Access•Mercedes Bonet, Magdalena Babinska et al.•ARTICLE•BMJ Global Health•2024

    INTRODUCTION: Pregnant women and their offspring are often at increased direct and indirect risks of adverse outcomes during epidemics and pandemics. A coordinated research response is paramount to ensure that this group is offered at least the same level of disease prevention, diagnosis, and care as the general population. We conducted a landscape analysis and held expert consultations to identify research efforts relevant to pregnant women affe…

  • Life Science 2.0

    Open Access•Michaela Vallin, G Tomson et al.•ARTICLE•Global Health Action•2024

    The COVID-19 pandemic put the life science sector to the test. Vaccines were developed at unprecedented speed, benefiting from decades of fundamental research and now honoured by a Nobel Prize. However, we saw that the fruits of science were inequitably distributed. Most low- and middle-income countries were left behind, deepening the inequalities that the Sustainable Development Goals were set to reduce. We argue that the life science sector mus…

  • Beyond buzzwords

    Open Access•Maeve Cook-Deegan, Kerem Böge et al.•ARTICLE•Global Health Action•2024

    BACKGROUND: Germany has increased its political and financial commitment for global health, but this needs to be backed by a robust global health research ecosystem with strong partnerships in low- and middle-income countries (LMICs). OBJECTIVE: This article suggests pathways for empowering researchers to operate beyond their disciplinary silos and strengthen partnerships across sectors and countries. The authors identify barriers and enablers of…

  • Beyond proximity

    Open Access•Oghenebrume Wariri, Winfred Dotse‐Gborgbortsi et al.•ARTICLE•BMJ Global Health•2025

    INTRODUCTION: Stillbirths are disproportionately concentrated in sub-Saharan Africa, where geographical accessibility to basic/comprehensive emergency obstetric and newborn care (BEmONC and CEmONC) significantly influences maternal and perinatal outcomes. This study describes stillbirth rates within healthcare facilities in The Gambia and examines their distribution in relation to the geographical accessibility of these facilities. METHODS: We an…

  • “I live with pain, it cannot go away”

    Open Access•Esin Nkereuwem, Oluwatosin Nkereuwem et al.•ARTICLE•PLOS Global Public Health•2025

    Childhood and adolescent tuberculosis (TB) survivors often face ongoing challenges even after completing their treatment. While the biomedical aspects of TB recovery are well studied, there is still limited understanding of how young survivors cope with the long-term impact of TB on their daily lives, development, and aspirations. Guided by an illness-narrative and phenomenological perspective, this qualitative study explored the lived experience…

  • Serological survey to determine measles and rubella immunity gaps across age and geographic locations in The Gambia

    Open Access•Oghenebrume Wariri, Abdul Khalie Muhammad et al.•ARTICLE•Global Health Action•2025

    Vaccine coverage and disease surveillance data are valuable for monitoring protection against vaccine-preventable diseases; however, they do not directly measure population immunity. High-quality, representative serological studies can provide key insights into immunity gaps, outbreak susceptibility, and inform targeted vaccination strategies, even in high-performing immunization programs. This study aims to estimate location-specific and age-spe…

  • Operationalizing African self-reliance in vaccine manufacturing

    Open Access•Chiluba Mwila, Anna Mia Ekström et al.•ARTICLE•Global Health Action•2025

    The COVID-19 pandemic underscored Africa's urgent need for vaccine security and self-reliance. In response, the African Union and Africa Centers for Disease Control and Prevention (CDC) established the Framework for Action (FFA) through the Platform for Harmonized African Health Products Manufacturing (PHAHM), with a goal of 60% local vaccine production by 2040. During 2024, Africa CDC, Karolinska Institutet, and Charité Universitätsmedizin Berli…

Medicine (12 works) · Vaccine Coverage and Hesitancy (9 works) · Environmental health (8 works) · Political science (6 works) · Vaccination (6 works) · Economic growth (5 works) · Public health (5 works) · Demography (4 works) · Economics (4 works) · Global Health and Surgery (4 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae